Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick L McGeer

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|March 8, 2014
Effective strategies for translating basic research into clinical success in Alzheimer's diseasePatrick L McGeer
Lancet (London, England)|October 23, 2008
Amyloid-beta vaccination for Alzheimer's dementiaPatrick L McGeer
Journal of Leukocyte Biology|March 12, 2003
Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAPAndis Klegeris, Patrick L McGeer
Experimental Neurology|March 1, 2002
Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosisClaudia Schwab, Patrick L McGeer
Science of Aging Knowledge Environment : SAGE KE|July 10, 2004
Immunotherapy for Alzheimer's diseasePatrick L McGeer, Edith McGeer
Biochemical and Biophysical Research Communications|April 27, 2007
Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112Andis Klegeris, Patrick L McGeer
Neurobiology of Aging|January 18, 2011
Weak BMAA toxicity compares with that of the dietary supplement β-alanineMoonhee Lee, Patrick L McGeer
Nature Medicine|February 5, 2004
Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer diseaseHaruhiko Akiyama, Patrick L McGeer
Current Alzheimer Research|June 25, 2005
Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative diseaseAndis Klegeris, Patrick L McGeer
Glia|March 22, 2005
Chymotrypsin-like proteases contribute to human monocytic THP-1 cell as well as human microglial neurotoxicityAndis Klegeris, Patrick L McGeer
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|March 8, 2014
Effective strategies for translating basic research into clinical success in Alzheimer's diseasePatrick L McGeer
Lancet (London, England)|October 23, 2008
Amyloid-beta vaccination for Alzheimer's dementiaPatrick L McGeer
Journal of Leukocyte Biology|March 12, 2003
Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAPAndis Klegeris, Patrick L McGeer
Experimental Neurology|March 1, 2002
Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosisClaudia Schwab, Patrick L McGeer
Science of Aging Knowledge Environment : SAGE KE|July 10, 2004
Immunotherapy for Alzheimer's diseasePatrick L McGeer, Edith McGeer
Biochemical and Biophysical Research Communications|April 27, 2007
Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112Andis Klegeris, Patrick L McGeer
Neurobiology of Aging|January 18, 2011
Weak BMAA toxicity compares with that of the dietary supplement β-alanineMoonhee Lee, Patrick L McGeer
Nature Medicine|February 5, 2004
Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer diseaseHaruhiko Akiyama, Patrick L McGeer
Current Alzheimer Research|June 25, 2005
Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative diseaseAndis Klegeris, Patrick L McGeer
Glia|March 22, 2005
Chymotrypsin-like proteases contribute to human monocytic THP-1 cell as well as human microglial neurotoxicityAndis Klegeris, Patrick L McGeer
Pageof 14